KIM-1

2 papers

Humans1
Animals1

Funding

1 grant since 2021

National Cancer InstituteUS$424.6k

Clinical characterization of Kidney Injury Molecule-1 (KIM-1) as a Biomarker in Renal Cell Carcinoma
National Cancer InstituteBeth Israel Deaconess Medical CenterUS$424.6k2021–2026

Latest

4 in 12 months

Xi Bao Yu Fen Zi Mian Yi Xue Za ZhiYesterday

Protective mechanism of urolithin A against alcoholic kidney injury through ferroptosis regulation

Experiments in miceUrolithin A

Journal of Korean Medical Science4 Aug

Role of Renal Biomarkers in Sarcopenia or Frailty in Patients With Liver Cirrhosis

Cross-sectional study of 78 peopleLiver cirrhosis

ADA Scientific Sessions 2026 Abstract5 Jun

Large-Scale Proteomic Discovery of Prognostic and Treatment-Responsive CKD Biomarkers in SELECT

Trial in peopleBiomarkers

GSA 2025 Abstract3 Jan

Association of Urinary Biomarkers and Joint Longitudinal Cognitive-Gait Trajectories: Health ABC Findings

Study in peopleBiomarkers